Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 44 Neoplasm Metastasis 19 Liver Neoplasms 18 Colorectal Neoplasms 15 Cholangiocarcinoma 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Colonic Neoplasms 9 Breast Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 6 Rectal Neoplasms 6 Thyroid Neoplasms 5 Pain 4 Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Thyroid Cancer, Papillary 3 Prostatic Neoplasms 3 Leiomyoma 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Hyperaldosteronism 2 Hepatitis B 2 Gallbladder Neoplasms 2

Interventions

Sorafenib 2 nimotuzumab 1 lenvatinib 1 atezolizumab 1 Tirapazamine 1 Stents 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Ethiodized Oil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HCC × Radiofrequency Ablation × Clear all

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡